Elevated Preoperative Serum CA19-9 Levels in Patients with Hepatocellular Carcinoma Is Associated with Poor Prognosis after Resection

Serum levels of the tumor marker CA19-9 have been reported to be elevated in patients with hepatocellular carcinoma (HCC), but its clinicopathologic significance is still unknown. A cohort of 304 patients undergoing surgical resection for HCC and having preoperative CA19-9 data was enrolled in this...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yu-Ling, Chen, Chien-Hung, Hu, Rey-Heng, Ho, Ming-Chih, Jeng, Yung-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694498/
https://www.ncbi.nlm.nih.gov/pubmed/23843733
http://dx.doi.org/10.1155/2013/380797

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694498/
https://www.ncbi.nlm.nih.gov/pubmed/23843733
http://dx.doi.org/10.1155/2013/380797

Ejemplares similares